Fibroblast Growth Factor 23 and Incidence of Subarachnoid Hemorrhage: Nested Case-Control Study

Stroke

Volumn 46, Issue 11, 2015, Pages 3260-3262

  Söderholm, Martin ^a,b   Engström, Gunnar ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

fibroblast growth factors; risk factors; subarachnoid hemorrhage

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; ICD-9; INCIDENCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING; SUBARACHNOID HEMORRHAGE; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD; COHORT ANALYSIS; LONGITUDINAL STUDY; ODDS RATIO; PROSPECTIVE STUDY; STATISTICAL MODEL; SWEDEN;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; INCIDENCE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; SUBARACHNOID HEMORRHAGE; SWEDEN;

EID: 84946479248     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.010565     Document Type: Article

References (15)

1. Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Chronic Renal Insufficiency Cohort (CRIC) Study Group Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011 305 2432 2439. doi: 10.1001/jama.2011.826
2. Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Chronic Renal Insufficiency Cohort Fibroblast growth factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol 2012 7 1155 1162. doi: 10.2215/CJN.13281211
3. Ix JH, Katz R, Kestenbaum BR, de Boer IH, Chonchol M, Mukamal KJ, Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol 2012 60 200 207. doi: 10.1016/j.jacc.2012.03.040
4. Kestenbaum B, Sachs MC, Hoofnagle AN, Siscovick DS, Ix JH, Robinson-Cohen C, Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis. Circ Heart Fail 2014 7 409 417. doi: 10.1161/CIRCHEARTFAILURE.113.000952
5. Gutiérrez OM, Wolf M, Taylor EN, Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clin J Am Soc Nephrol 2011 6 2871 2878. doi: 10.2215/CJN.02740311
6. Wright CB, Dong C, Stark M, Silverberg S, Rundek T, Elkind MS, Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS). Neurology 2014 82 1700 1706. doi: 10.1212/WNL.0000000000000410
7. Söderholm M, Zia E, Hedblad B, Engström G, Leukocyte count and incidence of subarachnoid haemorrhage: a prospective cohort study. BMC Neurol 2014 14 71. doi: 10.1186/1471-2377-14-71
8. Frösen J, Tulamo R, Paetau A, Laaksamo E, Korja M, Laakso A, Saccular intracranial aneurysm: pathology and mechanisms. Acta Neuropathol 2012 123 773 786. doi: 10.1007/s00401-011-0939-3
9. Zia E, Melander O, Björkbacka H, Hedblad B, Engström G, Total and differential leucocyte counts in relation to incidence of stroke subtypes and mortality: a prospective cohort study. J Intern Med 2012 272 298 304. doi: 10.1111/j.1365-2796.2012.02526.x
10. Pero RW, Olsson A, Bryngelsson C, Carlsson S, Janzon L, Berglund G, Quality control program for storage of biologically banked blood specimens in the Malmö Diet and Cancer Study. Cancer Epidemiol Biomarkers Prev 1998 7 803 808
11. Assarsson E, Lundberg M, Holmquist G, Björkesten J, Thorsen SB, Ekman D, Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One 2014 9 e95192. doi: 10.1371/journal.pone.0095192
12. Data package Proseek Multiplex CVD I. Olink Bioscience. http://www.olink.com/sites/default/files/0969v1.1ProseekMultiplexCVDIDataPackage-final.pdf. Accessed September 28, 2014
13. Panwar B, Jenny NS, Howard VJ, Wadley VG, Muntner P, Kissela BM, Fibroblast growth factor 23 and risk of incident stroke in community-living adults. Stroke 2015 46 322 328. doi: 10.1161/STROKEAHA.114.007489
14. Shah NH, Dong C, Elkind MS, Sacco RL, Mendez AJ, Hudson BI, Fibroblast growth factor 23 is associated with carotid plaque presence and area: The Northern Manhattan Study. Arterioscler Thromb Vasc Biol 2015 35 2048 2053
15. Lim K, Lu TS, Molostvov G, Lee C, Lam FT, Zehnder D, Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 2012 125 2243 2255. doi: 10.1161/CIRCULATIONAHA.111.053405